Organ Preservation Solutions

Global Organ Preservation Solutions Market to Reach US$361.5 Million by 2030

The global market for Organ Preservation Solutions estimated at US$271.8 Million in the year 2024, is expected to reach US$361.5 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Static Cold Storage, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$161.8 Million by the end of the analysis period. Growth in the Hypothermic Machine Perfusion segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$73.1 Million While China is Forecast to Grow at 4.6% CAGR

The Organ Preservation Solutions market in the U.S. is estimated at US$73.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$57.1 Million by the year 2030 trailing a CAGR of 4.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Organ Preservation Solutions - Key Trends and Drivers

Organ preservation solutions are indispensable in the field of transplant medicine, serving the critical function of maintaining the viability of organs from the time they are harvested until they are transplanted into the recipient. These solutions are specially formulated to minimize cellular damage and extend the preservation period, ensuring that organs remain functional and viable for transplantation. The development and use of organ preservation solutions have evolved significantly, with various chemical compositions being tailored to meet the preservation needs of different organs and varying preservation durations. Notable solutions include the University of Wisconsin (UW) solution, Histidine-Tryptophan-Ketoglutarate (HTK) solution, and Celsior solution, each designed to optimize outcomes by reducing cold ischemia time and improving post-transplant organ function. The market for these solutions is expanding as advancements in organ preservation technology continue to emerge, and the global demand for organ transplants increases due to a rising incidence of organ failure.

One of the significant trends in the organ preservation solutions market is the ongoing research and development aimed at enhancing the efficacy and performance of these solutions. Researchers are exploring innovative techniques such as oxygenated perfusion, which involves continuously supplying oxygen to the organs during preservation to maintain cellular metabolism. Additionally, the inclusion of antioxidants and other protective agents in preservation solutions is being investigated to reduce oxidative stress and cellular damage during storage. Another promising advancement is the increasing use of machine perfusion technologies, which allow for the continuous circulation of preservation solutions through the organ. This technique has shown significant potential in extending preservation times and improving transplant success rates by maintaining organ functionality closer to physiological conditions. These technological advancements are vital in addressing the critical shortage of donor organs and improving the overall efficiency of the transplantation process. The adoption of personalized medicine approaches, where preservation solutions are customized to meet the specific needs of individual organs and patients, is expected to further drive innovation and improvements in this field.

The growth in the organ preservation solutions market is driven by several factors, including the rising incidence of chronic diseases such as diabetes, hypertension, and heart disease, which lead to organ failure and the subsequent need for transplants. The growing aging population also contributes to the increased demand for organ transplants, as older individuals are more likely to suffer from conditions that necessitate organ replacement. Furthermore, the number of organ transplant procedures is increasing globally, driven by advancements in surgical techniques and improved post-transplant care. Technological advancements in preservation methods, such as hypothermic and normothermic perfusion, are significantly enhancing organ viability and driving market demand. Hypothermic perfusion involves cooling the organ and continuously perfusing it with a cold preservation solution, while normothermic perfusion maintains the organ at normal body temperature and provides oxygenated blood or preservation solution. These methods have shown improved outcomes in terms of organ viability and function post-transplant. Additionally, the expanding healthcare infrastructure in emerging economies and increased government initiatives to support organ donation and transplantation are contributing to market growth. For example, many countries are implementing policies and programs to encourage organ donation and improve the management of donor organs. Improvements in donor organ management practices, such as better matching of donors and recipients and more efficient logistics for organ transportation, are further enhancing the success rates of transplants. Moreover, the development of innovative preservation solutions with better efficacy and longer preservation times is expected to sustain market growth in the coming years. The combined effect of these factors is propelling the organ preservation solutions market toward a promising future, characterized by improved transplant outcomes and increased availability of viable organs for transplantation.

SCOPE OF STUDY:

The report analyzes the Organ Preservation Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Other Techniques); Organ Type (Kidneys, Liver, Lungs, Heart, Other Organ Types)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 13 Featured) -

• 21st Century Medicine
• BioLife Solutions, Inc.
• Dr. Franz Köhler Chemie GmbH
• Essential Pharmaceuticals, LLC
• Lifeline Scientific, Inc.
• Preservation Solutions, Inc.
• XVIVO Perfusion AB

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.